Tiamulin Market: Regional Analysis
North America is expected to hold
a dominant position in the global Tiamulin
Marketf over the forecast period, owing to the presence of key players in
the region along with several strategic mergers and acquisitions amongst the
key players. For instance, in 2015, US-based Eli Lilly and Company acquired
Novartis Animal Health Inc. and its product –Denagard (tiamulin hydrogen
fumarate) and strengthen the position of Eli Lilly and Company’s animal health
business arm Elanco US, Inc.
Asia Pacific tiamulin market is
expected to witness significant growth over forecast period, owing to increase
in the number of pig farms in the region. For instance, according to report by
Federal Statistical Office in 2014, China was the largest producer of pork with
around 48% of the total pork produced worldwide. Such increasing production of
pork is expected to propel the demand for antibiotics such as Tiamulin for the
treatment of pigs.
Furthermore, Europe tiamulin
market is expected to witness significant growth over the forecast period,
owing to high rates of pork production, which is expected to increase demand
for antibiotic drugs, such as Tiamulin. For instance, according to a report by
National Pork Board, Europe is the second largest producer of pork worldwide with
around 23,866 thousand metric tons pork produced in 2016 and 23,675 thousand
metric tons pork produced in 2017.
Tiamulin is a pleuromutilin
antibiotic drug, which is derived semi-synthetically from natural compound—
pleuromutilin—originally produced by the mushroom–clitopilus scyphoides.
Tiamulin is primarily used as veterinary medicine for treatment of pneumonia,
prophylaxis of dysentery, and mycoplasmal infections in pigs and poultry. It
acts by inhibiting protein synthesis at ribosomal level and is present in
powder and injectable formulations. Antibiotic properties of Tiamulin aid in
treatment of wide range of diseases caused by bacteria.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2036
Tiamulin Market: Drivers
Tiamulin aids in treatment and
prophylaxis of several diseases such as dysentery, pneumonia, and mycoplasmal
infections in pigs and poultry. Increasing demand for pork and poultry meat
along with increase in pig farming and poultry is expected to propel demand for
antibiotic drug tiamulin and fuel global tiamulin market growth. This is owing
to the susceptibility of pigs and poultry animals to various types of
infections and diseases. According to a report by National Pork Board, China
was the largest pork-producing country in the world. The country produced around 52,990 thousand
metric tons of pork in 2016, which was increased to 53,400 thousand metric tons
in 2017.
According to a report by Federal
Statistical Office in 2014, the U.S. was the largest producer of poultry meat
with around 18% of the total meat produced worldwide. High production of
poultry meat is expected to increase demand for Tiamulin antibiotic drug to
treat poultry animals from various infections. This in turn is expected to
propel growth of the Tiamulin market in the region over the forecast period.
Furthermore, initiatives by
various private and government organizations for spreading awareness for use of
antibiotics in pig farms is expected to propel global tiamulin market growth
over forecast period. For instance, in 2017, National Pork Board celebrated The
U.S. Antibiotic Awareness Week and World Antibiotic Awareness Week with
organizations such as the U.S. Centers for Disease Control and Prevention (CDC)
for spreading awareness for use of antibiotic drugs in pigs.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/tiamulin-market-2036
Tiamulin Market: Restraint
Use of Tiamulin results in some
side effects, which is expected to be a major factor hindering growth of the
Tiamulin market over the forecast period. Tiamulin injection can cause pain in
the animals and long-term treatment with Tiamulin results in its resistance in
bacteria.
Furthermore, stringent regulation
by U.S. Food and Drug Administration for sale of Tiamulin drugs is also
expected to adversely affect the tiamulin market growth. For instance, in 2013,
U.S. Food and Drug Administration drafted new guidelines to ban the sale of any
medically use antibiotics for non-medical applications. In 2014, Novartis
Animal Health Inc. (now a part of Eli Lilly and Company) received warning form
FDA, as it promoted its swine antibiotic product— Denagard (tiamulin hydrogen
fumarate) for growth-promotion aspects.
Tiamulin Market: Key Players
Key players operating in the
global Tiamulin market include Elanco Inc., Hester Biosciences Limited,
Huvepharma AD, Jiangsu SEL Biochem, Shandong Shengli Co Ltd, and others.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2036
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment